• The Company's first grant application is the USDA Rural Utilities Service (RUS) Distance Learning and Telemedicine (DLT) Grant Program submitted on April 27, 2024

SALT LAKE CITY, UT / ACCESSWIRE / June 26, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, is pleased to announce its successful registration on SAM.gov, the official U.S. federal funding platform. The System for Award Management (SAM.gov) is a U.S. government website that provides contractors and organizations the ability to register and apply for federal grants, renew contracts, and access data to support their grant application processes. This pivotal achievement not only enables KindlyMD to obtain funds for federal grants and contracts, including those with the Department of Veterans Affairs, but also opens the door to a broad spectrum of federal funding opportunities crucial for advancing its mission of providing comprehensive healthcare solutions.

Following the Company's SAM.gov registration, KindlyMD submitted its first grant application for the United States Department of Agriculture (USDA) Rural Utilities Service (RUS) Distance Learning and Telemedicine (DLT) Grant Program. Submitted on April 27, 2024, this application seeks to secure funding to expand the Company's Complete Care telehealth program in rural communities in Utah. This innovative program combines traditional primary care with pain management strategies and mental health services to deliver comprehensive telehealth treatment across Utah's rural communities. The program's goal is to deliver effective healthcare through an interconnected network of telemedicine clinics, addressing the unique challenges faced by rural populations.

"We are thrilled to reach this significant milestone of SAM.gov registration and our first grant application submission," said KindlyMD Founder and CEO Tim Pickett, PA-C. "SAM registration is not just a bureaucratic step; it is a critical enabler allowing Kindly MD to expand its opportunities through federal funding and contracts, marking a significant step in our organization's growth and our ability to participate in the federal marketplace. The opportunities provided by these grants will enable us to broaden our reach across rural communities and deliver high-quality healthcare directly to patients through our Complete Care telehealth program."

The fiscal year 2024 DLT grant application period closed on April 29, 2024, with KindlyMD applying for the full $1,000,000 grant to implement distance learning and telemedicine systems that will provide vital educational and medical services to remote communities.

In addition to the RUS-DLT grant, KindlyMD is strategically positioned to pursue several other grant opportunities that align with our integrated care model. These include:

• Screening, Brief Intervention, and Referral to Treatment (SBIRT) Grants, supporting services in primary care and community settings for substance use disorders.
• Rural Opioid Technical Assistance Grants (ROTA), enhancing education and technical assistance related to opioid addiction prevention, treatment, and recovery services.
• Substance Abuse Treatment Telehealth Network Grant Program, focused on expanding access to substance use disorder treatment services through telehealth care.
• Medication-Assisted Treatment - Prescription Drug and Opioid Addiction (MAT-PDOA) Grants, aimed at increasing capacity for providing comprehensive medication-assisted treatment and behavioral therapies.
• Community Mental Health Services Block Grant (MHBG) and Primary and Behavioral Health Care Integration (PBHCI) Grants, promoting the integration of primary care services into mental health settings.

The Company's mission is to provide comprehensive, patient-focused care that improves quality of life. With our strategic SAM.gov registration and exploration of relevant federal grants, the Company is poised to make a meaningful impact on healthcare delivery.

About KindlyMD

KindlyMD™ is a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies to offer patients comprehensive care and reduce the addiction and dependency of opioid use in the U.S. KindlyMD currently operates four centers including the largest alternative pain treatment center in Utah. With a focus on holistic pain management through its specialty outpatient clinical services, including, where appropriate, the recommendation of medical cannabis by KindlyMD healthcare providers, KindlyMD is providing better patient health outcomes.

For more information, please visit www.kindlymd.com.

Forward-Looking Statements

This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as "should," "may," "intends," "anticipates," "believes," "estimates," "projects," "forecasts," "expects," "plans," and "proposes." These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading "Risk Factors" in KindlyMD, Inc.'s Annual Report on Form 10-K for the fiscal year ended December 31, 2022. KindlyMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.

Investor Relations Contact:

Valter Pinto, Managing Director
KCSA Strategic Communications
(212) 896-1254
This email address is being protected from spambots. You need JavaScript enabled to view it.